Carlson College of Veterinary Medicine

E. C. Miltner and Bermudez, L. E., “Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials.”, Antimicrobial agents and chemotherapy, vol. 44, no. 7, pp. 1990-4, 2000.

R. Tenant and Bermudez, L. E., “Mycobacterium avium genes upregulated upon infection of Acanthamoeba castellanii demonstrate a common response to the intracellular environment.”, Current microbiology, vol. 52, no. 2, pp. 128-33, 2006.

M. J. Harriff, Danelishvili, L., Wu, M., Wilder, C., McNamara, M., Kent, M. L., and Bermudez, L. E., “Mycobacterium avium genes MAV_5138 and MAV_3679 are transcriptional regulators that play a role in invasion of epithelial cells, in part by their regulation of CipA, a putative surface protein interacting with host cell signaling pathways.”, Journal of bacteriology, vol. 191, no. 4, pp. 1132-42, 2009.

Y. Yamazaki, Danelishvili, L., Wu, M., Macnab, M., and Bermudez, L. E., “Mycobacterium avium genes associated with the ability to form a biofilm.”, Applied and environmental microbiology, vol. 72, no. 1, pp. 819-25, 2006.

M. McNamara, Danelishvili, L., and Bermudez, L. E., “The Mycobacterium avium ESX-5 PPE protein, PPE25-MAV, interacts with an ESAT-6 family Protein, MAV_2921, and localizes to the bacterial surface.”, Microbial pathogenesis, vol. 52, no. 4, pp. 227-38, 2012.

F. J. Sangari, Goodman, J., and Bermudez, L. E., “Mycobacterium avium enters intestinal epithelial cells through the apical membrane, but not by the basolateral surface, activates small GTPase Rho and, once within epithelial cells, expresses an invasive phenotype.”, Cellular microbiology, vol. 2, no. 6, pp. 561-8, 2000.

L. E. Bermudez, Inderlied, C. B., and Young, L. S., “Mycobacterium avium complex in AIDS.”, Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.

C. B. Inderlied, Kemper, C. A., and Bermudez, L. E., “The Mycobacterium avium complex.”, Clinical microbiology reviews, vol. 6, no. 3, pp. 266-310, 1993.

S. J. Rose and Bermudez, L. E., “Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection.”, Infection and immunity, vol. 82, no. 1, pp. 405-12, 2014.

L. E. Bermudez and Sangari, F. J., “Mycobacterial invasion of epithelial cells.”, Sub-cellular biochemistry, vol. 33, pp. 231-49, 2000.

L. S. Young, Bermudez, L. E., and Inderlied, C. B., “Mycobacteria and AIDS: treatment, prevention and future prospects.”, Research in microbiology, vol. 143, no. 4, pp. 420-2, 1992.

L. S. Young, Gascon, R., Alam, S., and Bermudez, L. E., “Monoclonal antibodies for treatment of gram-negative infections.”, Reviews of infectious diseases, vol. 11 Suppl 7, pp. S1564-71, 1989.

C. M. Whipps, Boorom, K., Bermudez, L. E., and Kent, M. L., “Molecular characterization of Blastocystis species in Oregon identifies multiple subtypes.”, Parasitology research, vol. 106, no. 4, pp. 827-32, 2010.

J. Early and Bermudez, L. E., “Mimicry of the Pathogenic Mycobacterium Vacuole in vitro Elicits the Bacterial Intracellular Phenotype, Including Early-onset Macrophage Cell Death.”, Infection and immunity, 2011.

L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.

L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., “Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.

L. E. Bermudez, Wagner, D., and Sosnowska, D., “Mechanisms of Mycobacterium avium pathogenesis.”, Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.

S. L. Cirillo, Bermudez, L. E., El-Etr, S. H., Duhamel, G. E., and Cirillo, J. D., “Legionella pneumophila entry gene rtxA is involved in virulence.”, Infection and immunity, vol. 69, no. 1, pp. 508-17, 2001.

L. E. Bermudez and Young, L. S., “Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines.”, Research in microbiology, vol. 141, no. 2, pp. 241-3, 1990.

L. Broxmeyer, Sosnowska, D., Miltner, E., Chacon, O., Wagner, D., McGarvey, J., Barletta, R. G., and Bermudez, L. E., “Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.”, The Journal of infectious diseases, vol. 186, no. 8, pp. 1155-60, 2002.

O. Chacon, Bermudez, L. E., and Barletta, R. G., “Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis.”, Annual review of microbiology, vol. 58, pp. 329-63, 2004.

L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., “Isolation of two subpopulations of Mycobacterium avium within human macrophages.”, FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.

H. S. Wu, Kolonoski, P., Chang, Y. Y., and Bermudez, L. E., “Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice.”, Infection and immunity, vol. 68, no. 5, pp. 2979-84, 2000.

L. E. Bermudez, Petrofsky, M., and Sangari, F., “Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype.”, Cell biology international, vol. 28, no. 5, pp. 411-9, 2004.

L. E. Bermudez, Wu, M., and Young, L. S., “Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.”, The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.